Ito S, Abe K
Second Department of Internal Medicine, Tohoku University School of Medicine, Miyagi, Japan.
Nihon Jinzo Gakkai Shi. 1996 Mar;38(3):115-8.
Alterations in glomerular hemodynamics may play an important role in the progression of renal dysfunction. Accordingly, treating not only systemic hypertension, but also glomerular hypertension is important for conservation of renal function in patients with renal disease. However, glomerular capillary pressure does not necessarily change in parallel with systemic blood pressure due to unique mechanisms that control the resistance of glomerular afferent and efferent arterioles. While myogenic response and tubuloglomerular feedback play an important role in controlling afferent arteriolar resistance, angiotensin II is a major determinant of efferent arteriolar tone. Calcium antagonists block almost all mechanisms that constrict the afferent arteriole, rendering glomerular capillary pressure dependent on systemic pressure. On the other hand, angiotensin-converting enzyme inhibitors dilate efferent arterioles, thereby lowering glomerular capillary pressure. Such differences should be taken into account when selecting adequate drugs for the treatment of hypertension with various degrees of renal dysfunction.
肾小球血流动力学改变可能在肾功能不全的进展中起重要作用。因此,对于肾病患者,不仅要治疗全身性高血压,还要治疗肾小球高血压,这对保护肾功能很重要。然而,由于控制肾小球入球小动脉和出球小动脉阻力的独特机制,肾小球毛细血管压力不一定与全身血压平行变化。虽然肌源性反应和管球反馈在控制入球小动脉阻力中起重要作用,但血管紧张素II是出球小动脉张力的主要决定因素。钙拮抗剂几乎阻断了所有使入球小动脉收缩的机制,使肾小球毛细血管压力依赖于全身压力。另一方面,血管紧张素转换酶抑制剂使出球小动脉扩张,从而降低肾小球毛细血管压力。在为不同程度肾功能不全的高血压患者选择合适药物时,应考虑到这些差异。